S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Avoro Capital Advisors/Q2 2024

Avoro Capital Advisors

Period: Q2 2024 Β· Filed: 2024-08-14
View on SEC EDGAR β†—
AUM
$7.51B
Total portfolio value
Positions
41
Reported securities
Top Holding
UTHR
12.1% $910.7M
QoQ Changes
+3 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
UTHRUNITED THERAPEUTICS CORP$910.7M12.13%$319.01$555.91+74.3%
12.1%
MDGLMADRIGAL PHARMACEUTICALS INC$575.9M7.67%$279.31$528.10+89.1%
7.7%
ASNDASCENDIS PHARMA$572.3M7.62%$133.98$274.50+104.9%
7.6%
ARGXARGENX SE$532.6M7.09%$434.22$939.68+116.4%
7.1%
SRPTSAREPTA THERAPEUTICS INC$474.0M6.31%$156.75$19.28-87.7%
6.3%
KRYSKRYSTAL BIOTECH INC$446.8M5.95%$182.27$375.07+105.8%
6.0%
APLSAPELLIS PHARMACEUTICALS INC.$426.2M5.68%$36.29β€”
5.7%
BMRNBIOMARIN PHARMACEUTICAL INC$375.2M5.00%$82.13$58.99-28.2%
5.0%
CERECEREVEL THERAPEUTICS HLDNG$308.3M4.11%β€”β€”
4.1%
XBISPDR SERIES TRUST - S&P BIOTECH$281.4M3.75%$92.59$160.46+73.3%
3.8%
FOLDAMICUS THERAPEUTICS INC.$271.8M3.62%β€”β€”
3.6%
RNAMAVIDITY BIOSCIENCES INC$265.7M3.54%β€”β€”
3.5%
ARWRARROWHEAD PHARMACEUTICALS INC.$231.0M3.08%$26.05$83.99+222.4%
3.1%
XENEXENON PHARMACEUTICALS INC$220.9M2.94%$37.69$60.96+61.7%
2.9%
ITCIINTRA-CELLULAR THERAPIES INC$205.5M2.74%β€”β€”
2.7%
VERAVERA THERAPEUTICS INC$155.9M2.08%$36.29$41.20+13.5%
2.1%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$121.8M1.62%$41.80$18.95-54.7%
1.6%
KYMRKYMERA THERAPEUTICS INC$116.1M1.55%$30.95$113.51+266.8%
1.6%
ALNYALNYLAM PHARMCEUTICALS INC.$97.2M1.29%$243.32$312.78+28.6%
1.3%
IOVAIOVANCE BIOTHERAPEUTICS INC$93.8M1.25%$8.06$4.31-46.5%
1.3%
SLNOSOLENO THERAPEUTICS INC$85.3M1.14%$42.29β€”
1.1%
MRUSMERUS N V$80.2M1.07%β€”β€”
1.1%
SNDXSYNDAX PHARMACEUTICALS INC$79.8M1.06%$21.53$21.82+1.4%
1.1%
BCRXBIOCRYST PHARMACEUTICALS INC$77.7M1.03%$6.67$9.84+47.5%
1.0%
KURAKURA ONCOLOGY INC$72.9M0.97%$21.20$11.10-47.6%
1.0%
OCULOCULAR THERAPEUTIX INC$55.1M0.73%$6.66$9.64+44.7%
0.7%
MNKDMANNKIND CORP$45.7M0.61%$5.09$4.52-11.2%
0.6%
PCVXVAXCYTE INC$43.4M0.58%$76.94$58.39-24.1%
0.6%
SYRESPYRE THERAPEUTICS INC$43.2M0.58%$24.55$86.63+252.9%
0.6%
AUTLAUTOLUS THERAPEUTICS PLC$43.0M0.57%$3.47$1.58-54.5%
0.6%

Quarter-on-Quarter Activity

Q2 2024 vs. Q1 2024

New Positions (3)

TickerIssuerNotional
BCYCBICYCLE THERAPEUTICS PLC$14.2M
DYNDYNE THERAPEUTICS INC.$4.1M
NGNENEUROGENE INC$0.8M

Exited Positions (8)

TickerIssuerNotional
VKTXVIKING THERAPEUTICS INC$294.4M
ALPNALPINE IMMUNE SCIENCES INC$228.9M
MGNXMACROGENICS INC$90.5M
ROIVROIVANT SCIENCES LTD$49.0M
MRNSMARINUS PHARMACEUTICALS INC$37.4M
RCKTROCKET PHARMACEUTICALS INC$34.0M
CRSPCRISPR THERAPEUTICS AG$28.6M
KYTXKYVERNA THERAPEUTICS INC$11.8M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
MRUSMERUS N V$40.1M+52.4%
ALNYALNYLAM PHARMCEUTICALS INC.$52.4M+33.3%+28.6%
SLNOSOLENO THERAPEUTICS INC$15.8M+28.7%
ITCIINTRA-CELLULAR THERAPIES INC$34.2M+21.2%
OCULOCULAR THERAPEUTIX INC$-9.9M+12.7%+44.7%
RNAMAVIDITY BIOSCIENCES INC$117.1M+11.7%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$-7.8M+7.4%-54.7%
ASNDASCENDIS PHARMA$-27.3M+5.8%+104.9%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
SRPTSAREPTA THERAPEUTICS INC$-88.4M-30.9%-87.7%
XBISPDR SERIES TRUST - S&P BIOTECH$-126.7M-29.4%+73.3%
VERAVERA THERAPEUTICS INC$-71.1M-18.1%+13.5%
KURAKURA ONCOLOGY INC$-9.2M-8.0%-47.6%
SNDXSYNDAX PHARMACEUTICALS INC$-20.7M-7.9%+1.4%
KRYSKRYSTAL BIOTECH INC$-7.9M-4.8%+105.8%
BCRXBIOCRYST PHARMACEUTICALS INC$11.4M-3.7%+47.5%
MNKDMANNKIND CORP$5.0M-2.7%-11.2%
← Back to Hedge Funds